Status:
RECRUITING
Vivistim Registry for Paired VNS Therapy (GRASP)
Lead Sponsor:
MicroTransponder Inc.
Conditions:
Upper Extremity Problem
Eligibility:
All Genders
22+ years
Brief Summary
The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment...
Detailed Description
The registry is a data repository of information on patients considering implant of the Vivistim System. The Vivistim System is an FDA approved (P210007) device used to help improve upper limb motor d...
Eligibility Criteria
Inclusion
- Patients implanted with the Vivistim System for upper limb deficits associated with an ischemic stroke
Exclusion
- Not eligible for surgery
Key Trial Info
Start Date :
March 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05301140
Start Date
March 15 2023
End Date
December 31 2028
Last Update
October 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mt. Sinai
New York, New York, United States, 10029
2
Thomas Jefferson
Philadelphia, Pennsylvania, United States, 19107